Saturn V Capital Management LP 13F Holdings
CIK 0001964437 · AUSTIN, TX
As of Sep 30, 2025, Saturn V Capital Management LP reported 17 positions worth $456.0M in its SEC Form 13F filing.
Top 17 holdings
| Security | Ticker | Sector | Shares | Value | % of portfolio |
|---|---|---|---|---|---|
| ABIVAX SA | ABVX | Healthcare | 801,224 | $68.0M | 14.92% |
| AMYLYX PHARMACEUTICALS INC | AMLX | Healthcare | 4,604,878 | $62.6M | 13.72% |
| JAZZ PHARMACEUTICALS PLC | JAZZ | Healthcare | 300,610 | $39.6M | 8.69% |
| DYNE THERAPEUTICS INC | DYN | Healthcare | 2,674,469 | $33.8M | 7.42% |
| COGENT BIOSCIENCES INC | COGT | Healthcare | 2,025,041 | $29.1M | 6.38% |
| VAXCYTE INC | PCVX | Healthcare | 788,441 | $28.4M | 6.23% |
| CELCUITY INC | CELC | — | 473,828 | $23.4M | 5.13% |
| CG ONCOLOGY INC | CGON | Healthcare | 579,895 | $23.4M | 5.12% |
| DISC MEDICINE INC | IRON | Healthcare | 340,897 | $22.5M | 4.94% |
| PHARVARIS N V | PHVS | Healthcare | 886,332 | $22.1M | 4.85% |
| XENON PHARMACEUTICALS INC | XENE | Healthcare | 503,701 | $20.2M | 4.44% |
| CENTESSA PHARMACEUTICALS PLC | CNTA | Healthcare | 734,539 |